Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Clin Respir J. 2020 Dec;14(12):1144-1152. doi: 10.1111/crj.13251. Epub 2020 Sep 22.
The effectiveness of non-invasive mechanical ventilation (NIV) in the management of COPD patients suffering from acute respiratory failure (ARF) as a consequence of exacerbation of the disease, is well established. However, data on long-term outcomes and their predictors, including the individual response to NIV, are scarce.
To investigate predictors for short- and long-term mortality in this study population.
A retrospective cohort study was performed including all patients admitted to the Medium Respiratory Care Unit of Maastricht University Medical Center in Maastricht, the Netherlands, with hospitalized exacerbation of COPD (H-ECOPD) with ARF requiring NIV for the first time between January 2009 and December 2011. An extensive number of potential predictors of outcomes, including the response to NIV, were determined on admission and during hospitalization. Univariate and multivariate logistic regression was used for statistical analysis.
Seventy-eight consecutive patients with moderate to severe COPD (mean age 71.0 ± 10.7 years; 48.7% males) were included; In-hospital, 1-year and 2-year mortality rates were 14.1%, 43.6% and 56.4%, respectively. Independent risk factors for 2-year mortality were: advanced age (odds ratio(OR) 1.025; confidence interval (CI) 1.002-1.049; P = 0.037), prolonged NIV use more than 8 days (OR:1.054;CI:1.006-1.104; P = 0.027) and no successful response to NIV (OR:2.392;CI:1.297-4.413; P = 0.005).
Patients with an H-ECOPD requiring NIV for the first time, constitute a severely ill patient group with high in-hospital and 2-year mortality. This study identified advanced age, NIV use more than 8 days and unsuccessful response to NIV as clinical important independent predictors for long-term mortality.
无创机械通气(NIV)在治疗因疾病加重而导致急性呼吸衰竭(ARF)的 COPD 患者方面的有效性已得到充分证实。然而,关于长期结果及其预测因素的数据,包括对 NIV 的个体反应,仍然很少。
本研究旨在探讨该研究人群的短期和长期死亡率的预测因素。
本研究采用回顾性队列研究设计,纳入了 2009 年 1 月至 2011 年 12 月期间在荷兰马斯特里赫特大学医学中心中呼吸重症监护病房(Medium Respiratory Care Unit)首次因 COPD 加重并发 ARF 而接受 NIV 治疗的住院患者。入院时和住院期间确定了大量潜在的预后预测因素,包括对 NIV 的反应。使用单变量和多变量逻辑回归进行统计分析。
本研究纳入了 78 例中重度 COPD 患者(平均年龄 71.0 ± 10.7 岁,男性占 48.7%);住院期间、1 年和 2 年的死亡率分别为 14.1%、43.6%和 56.4%。2 年死亡率的独立危险因素包括:高龄(优势比(OR)为 1.025;95%置信区间(CI)为 1.002-1.049;P=0.037)、NIV 使用时间延长超过 8 天(OR:1.054;95%CI:1.006-1.104;P=0.027)和对 NIV 无反应(OR:2.392;95%CI:1.297-4.413;P=0.005)。
首次因 COPD 加重并发 ARF 而需要接受 NIV 治疗的患者构成了一个病情严重的患者群体,其住院期间和 2 年死亡率均较高。本研究确定了高龄、NIV 使用时间超过 8 天和对 NIV 无反应是长期死亡率的重要独立预测因素。